Global Infectious Disease Point of Care Diagnostics Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Infectious Disease Point of Care Diagnostics will have significant change from previous year. According to our (LP Information) latest study, the global Infectious Disease Point of Care Diagnostics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Infectious Disease Point of Care Diagnostics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Infectious Disease Point of Care Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Infectious Disease Point of Care Diagnostics market, reaching US$ million by the year 2028. As for the Europe Infectious Disease Point of Care Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Infectious Disease Point of Care Diagnostics players cover Abbott, Siemens, GE Healthcare, and Accriva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Point of Care Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Infectious Disease Point of Care Diagnostics will have significant change from previous year. According to our (LP Information) latest study, the global Infectious Disease Point of Care Diagnostics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Infectious Disease Point of Care Diagnostics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Infectious Disease Point of Care Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Infectious Disease Point of Care Diagnostics market, reaching US$ million by the year 2028. As for the Europe Infectious Disease Point of Care Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Infectious Disease Point of Care Diagnostics players cover Abbott, Siemens, GE Healthcare, and Accriva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Point of Care Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Over-the-counter (OTC) Testing Kits
- Prescription-based Testing Kits
- Bacterial Infections
- Fungal Infection
- Virus Infection
- Cardiovascular Infection
- Gastrointestinal Infection
- Sexually Transmitted Disease (STD) Infection
- Central Nervous System Infection
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Siemens
- GE Healthcare
- Accriva
- Terumo
- BioMerieux
- Diasorin
- Roche
- Danaher Corporation
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- Euroimmun
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Point of Care Diagnostics Market Size 2017-2028
2.1.2 Infectious Disease Point of Care Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Infectious Disease Point of Care Diagnostics Segment by Type
2.2.1 Over-the-counter (OTC) Testing Kits
2.2.2 Prescription-based Testing Kits
2.3 Infectious Disease Point of Care Diagnostics Market Size by Type
2.3.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Infectious Disease Point of Care Diagnostics Segment by Application
2.4.1 Bacterial Infections
2.4.2 Fungal Infection
2.4.3 Virus Infection
2.4.4 Cardiovascular Infection
2.4.5 Gastrointestinal Infection
2.4.6 Sexually Transmitted Disease (STD) Infection
2.4.7 Central Nervous System Infection
2.4.8 Other
2.5 Infectious Disease Point of Care Diagnostics Market Size by Application
2.5.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
3 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Disease Point of Care Diagnostics Market Size Market Share by Players
3.1.1 Global Infectious Disease Point of Care Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS BY REGIONS
4.1 Infectious Disease Point of Care Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
4.3 APAC Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
4.4 Europe Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
5.2 Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
5.3 Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022)
6.2 APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
6.3 APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Point of Care Diagnostics by Country (2017-2022)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Point of Care Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Disease Point of Care Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Infectious Disease Point of Care Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Infectious Disease Point of Care Diagnostics Forecast
10.1.3 APAC Infectious Disease Point of Care Diagnostics Forecast
10.1.4 Europe Infectious Disease Point of Care Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast
10.2 Americas Infectious Disease Point of Care Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Infectious Disease Point of Care Diagnostics Market Forecast
10.2.2 Canada Infectious Disease Point of Care Diagnostics Market Forecast
10.2.3 Mexico Infectious Disease Point of Care Diagnostics Market Forecast
10.2.4 Brazil Infectious Disease Point of Care Diagnostics Market Forecast
10.3 APAC Infectious Disease Point of Care Diagnostics Forecast by Region (2023-2028)
10.3.1 China Infectious Disease Point of Care Diagnostics Market Forecast
10.3.2 Japan Infectious Disease Point of Care Diagnostics Market Forecast
10.3.3 Korea Infectious Disease Point of Care Diagnostics Market Forecast
10.3.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Forecast
10.3.5 India Infectious Disease Point of Care Diagnostics Market Forecast
10.3.6 Australia Infectious Disease Point of Care Diagnostics Market Forecast
10.4 Europe Infectious Disease Point of Care Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Infectious Disease Point of Care Diagnostics Market Forecast
10.4.2 France Infectious Disease Point of Care Diagnostics Market Forecast
10.4.3 UK Infectious Disease Point of Care Diagnostics Market Forecast
10.4.4 Italy Infectious Disease Point of Care Diagnostics Market Forecast
10.4.5 Russia Infectious Disease Point of Care Diagnostics Market Forecast
10.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Infectious Disease Point of Care Diagnostics Market Forecast
10.5.2 South Africa Infectious Disease Point of Care Diagnostics Market Forecast
10.5.3 Israel Infectious Disease Point of Care Diagnostics Market Forecast
10.5.4 Turkey Infectious Disease Point of Care Diagnostics Market Forecast
10.5.5 GCC Countries Infectious Disease Point of Care Diagnostics Market Forecast
10.6 Global Infectious Disease Point of Care Diagnostics Forecast by Type (2023-2028)
10.7 Global Infectious Disease Point of Care Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Infectious Disease Point of Care Diagnostics Product Offered
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Siemens
11.2.1 Siemens Company Information
11.2.2 Siemens Infectious Disease Point of Care Diagnostics Product Offered
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Siemens Main Business Overview
11.2.5 Siemens Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Accriva
11.4.1 Accriva Company Information
11.4.2 Accriva Infectious Disease Point of Care Diagnostics Product Offered
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Accriva Main Business Overview
11.4.5 Accriva Latest Developments
11.5 Terumo
11.5.1 Terumo Company Information
11.5.2 Terumo Infectious Disease Point of Care Diagnostics Product Offered
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Terumo Main Business Overview
11.5.5 Terumo Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Diasorin
11.7.1 Diasorin Company Information
11.7.2 Diasorin Infectious Disease Point of Care Diagnostics Product Offered
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Diasorin Main Business Overview
11.7.5 Diasorin Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Infectious Disease Point of Care Diagnostics Product Offered
11.8.3 Roche Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Information
11.9.2 Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Danaher Corporation Main Business Overview
11.9.5 Danaher Corporation Latest Developments
11.10 BD
11.10.1 BD Company Information
11.10.2 BD Infectious Disease Point of Care Diagnostics Product Offered
11.10.3 BD Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 BD Main Business Overview
11.10.5 BD Latest Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Information
11.11.2 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Bio-Rad Laboratories Main Business Overview
11.11.5 Bio-Rad Laboratories Latest Developments
11.12 Cavidi
11.12.1 Cavidi Company Information
11.12.2 Cavidi Infectious Disease Point of Care Diagnostics Product Offered
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Cavidi Main Business Overview
11.12.5 Cavidi Latest Developments
11.13 Cepheid
11.13.1 Cepheid Company Information
11.13.2 Cepheid Infectious Disease Point of Care Diagnostics Product Offered
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Cepheid Main Business Overview
11.13.5 Cepheid Latest Developments
11.14 Diaxonhit
11.14.1 Diaxonhit Company Information
11.14.2 Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Diaxonhit Main Business Overview
11.14.5 Diaxonhit Latest Developments
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Information
11.15.2 Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Eiken Chemical Main Business Overview
11.15.5 Eiken Chemical Latest Developments
11.16 EMD Millipore
11.16.1 EMD Millipore Company Information
11.16.2 EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 EMD Millipore Main Business Overview
11.16.5 EMD Millipore Latest Developments
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Information
11.17.2 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Epitope Diagnostic Main Business Overview
11.17.5 Epitope Diagnostic Latest Developments
11.18 Euroimmun
11.18.1 Euroimmun Company Information
11.18.2 Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Euroimmun Main Business Overview
11.18.5 Euroimmun Latest Developments
11.19 Gold Standard Diagnostics
11.19.1 Gold Standard Diagnostics Company Information
11.19.2 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Gold Standard Diagnostics Main Business Overview
11.19.5 Gold Standard Diagnostics Latest Developments
11.20 Hologic
11.20.1 Hologic Company Information
11.20.2 Hologic Infectious Disease Point of Care Diagnostics Product Offered
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Hologic Main Business Overview
11.20.5 Hologic Latest Developments
11.21 Immunetics
11.21.1 Immunetics Company Information
11.21.2 Immunetics Infectious Disease Point of Care Diagnostics Product Offered
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Immunetics Main Business Overview
11.21.5 Immunetics Latest Developments
11.22 InBios International
11.22.1 InBios International Company Information
11.22.2 InBios International Infectious Disease Point of Care Diagnostics Product Offered
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 InBios International Main Business Overview
11.22.5 InBios International Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Point of Care Diagnostics Market Size 2017-2028
2.1.2 Infectious Disease Point of Care Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Infectious Disease Point of Care Diagnostics Segment by Type
2.2.1 Over-the-counter (OTC) Testing Kits
2.2.2 Prescription-based Testing Kits
2.3 Infectious Disease Point of Care Diagnostics Market Size by Type
2.3.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Infectious Disease Point of Care Diagnostics Segment by Application
2.4.1 Bacterial Infections
2.4.2 Fungal Infection
2.4.3 Virus Infection
2.4.4 Cardiovascular Infection
2.4.5 Gastrointestinal Infection
2.4.6 Sexually Transmitted Disease (STD) Infection
2.4.7 Central Nervous System Infection
2.4.8 Other
2.5 Infectious Disease Point of Care Diagnostics Market Size by Application
2.5.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
3 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Disease Point of Care Diagnostics Market Size Market Share by Players
3.1.1 Global Infectious Disease Point of Care Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS BY REGIONS
4.1 Infectious Disease Point of Care Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
4.3 APAC Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
4.4 Europe Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
5.2 Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
5.3 Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022)
6.2 APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
6.3 APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Point of Care Diagnostics by Country (2017-2022)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Point of Care Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Disease Point of Care Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Infectious Disease Point of Care Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Infectious Disease Point of Care Diagnostics Forecast
10.1.3 APAC Infectious Disease Point of Care Diagnostics Forecast
10.1.4 Europe Infectious Disease Point of Care Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast
10.2 Americas Infectious Disease Point of Care Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Infectious Disease Point of Care Diagnostics Market Forecast
10.2.2 Canada Infectious Disease Point of Care Diagnostics Market Forecast
10.2.3 Mexico Infectious Disease Point of Care Diagnostics Market Forecast
10.2.4 Brazil Infectious Disease Point of Care Diagnostics Market Forecast
10.3 APAC Infectious Disease Point of Care Diagnostics Forecast by Region (2023-2028)
10.3.1 China Infectious Disease Point of Care Diagnostics Market Forecast
10.3.2 Japan Infectious Disease Point of Care Diagnostics Market Forecast
10.3.3 Korea Infectious Disease Point of Care Diagnostics Market Forecast
10.3.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Forecast
10.3.5 India Infectious Disease Point of Care Diagnostics Market Forecast
10.3.6 Australia Infectious Disease Point of Care Diagnostics Market Forecast
10.4 Europe Infectious Disease Point of Care Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Infectious Disease Point of Care Diagnostics Market Forecast
10.4.2 France Infectious Disease Point of Care Diagnostics Market Forecast
10.4.3 UK Infectious Disease Point of Care Diagnostics Market Forecast
10.4.4 Italy Infectious Disease Point of Care Diagnostics Market Forecast
10.4.5 Russia Infectious Disease Point of Care Diagnostics Market Forecast
10.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Infectious Disease Point of Care Diagnostics Market Forecast
10.5.2 South Africa Infectious Disease Point of Care Diagnostics Market Forecast
10.5.3 Israel Infectious Disease Point of Care Diagnostics Market Forecast
10.5.4 Turkey Infectious Disease Point of Care Diagnostics Market Forecast
10.5.5 GCC Countries Infectious Disease Point of Care Diagnostics Market Forecast
10.6 Global Infectious Disease Point of Care Diagnostics Forecast by Type (2023-2028)
10.7 Global Infectious Disease Point of Care Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Infectious Disease Point of Care Diagnostics Product Offered
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Siemens
11.2.1 Siemens Company Information
11.2.2 Siemens Infectious Disease Point of Care Diagnostics Product Offered
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Siemens Main Business Overview
11.2.5 Siemens Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Accriva
11.4.1 Accriva Company Information
11.4.2 Accriva Infectious Disease Point of Care Diagnostics Product Offered
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Accriva Main Business Overview
11.4.5 Accriva Latest Developments
11.5 Terumo
11.5.1 Terumo Company Information
11.5.2 Terumo Infectious Disease Point of Care Diagnostics Product Offered
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Terumo Main Business Overview
11.5.5 Terumo Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Diasorin
11.7.1 Diasorin Company Information
11.7.2 Diasorin Infectious Disease Point of Care Diagnostics Product Offered
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Diasorin Main Business Overview
11.7.5 Diasorin Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Infectious Disease Point of Care Diagnostics Product Offered
11.8.3 Roche Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Information
11.9.2 Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Danaher Corporation Main Business Overview
11.9.5 Danaher Corporation Latest Developments
11.10 BD
11.10.1 BD Company Information
11.10.2 BD Infectious Disease Point of Care Diagnostics Product Offered
11.10.3 BD Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 BD Main Business Overview
11.10.5 BD Latest Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Information
11.11.2 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Bio-Rad Laboratories Main Business Overview
11.11.5 Bio-Rad Laboratories Latest Developments
11.12 Cavidi
11.12.1 Cavidi Company Information
11.12.2 Cavidi Infectious Disease Point of Care Diagnostics Product Offered
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Cavidi Main Business Overview
11.12.5 Cavidi Latest Developments
11.13 Cepheid
11.13.1 Cepheid Company Information
11.13.2 Cepheid Infectious Disease Point of Care Diagnostics Product Offered
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Cepheid Main Business Overview
11.13.5 Cepheid Latest Developments
11.14 Diaxonhit
11.14.1 Diaxonhit Company Information
11.14.2 Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Diaxonhit Main Business Overview
11.14.5 Diaxonhit Latest Developments
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Information
11.15.2 Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Eiken Chemical Main Business Overview
11.15.5 Eiken Chemical Latest Developments
11.16 EMD Millipore
11.16.1 EMD Millipore Company Information
11.16.2 EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 EMD Millipore Main Business Overview
11.16.5 EMD Millipore Latest Developments
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Information
11.17.2 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Epitope Diagnostic Main Business Overview
11.17.5 Epitope Diagnostic Latest Developments
11.18 Euroimmun
11.18.1 Euroimmun Company Information
11.18.2 Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Euroimmun Main Business Overview
11.18.5 Euroimmun Latest Developments
11.19 Gold Standard Diagnostics
11.19.1 Gold Standard Diagnostics Company Information
11.19.2 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Gold Standard Diagnostics Main Business Overview
11.19.5 Gold Standard Diagnostics Latest Developments
11.20 Hologic
11.20.1 Hologic Company Information
11.20.2 Hologic Infectious Disease Point of Care Diagnostics Product Offered
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Hologic Main Business Overview
11.20.5 Hologic Latest Developments
11.21 Immunetics
11.21.1 Immunetics Company Information
11.21.2 Immunetics Infectious Disease Point of Care Diagnostics Product Offered
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Immunetics Main Business Overview
11.21.5 Immunetics Latest Developments
11.22 InBios International
11.22.1 InBios International Company Information
11.22.2 InBios International Infectious Disease Point of Care Diagnostics Product Offered
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 InBios International Main Business Overview
11.22.5 InBios International Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Disease Point of Care Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Over-the-counter (OTC) Testing Kits
Table 3. Major Players of Prescription-based Testing Kits
Table 4. Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
Table 13. Infectious Disease Point of Care Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Infectious Disease Point of Care Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Infectious Disease Point of Care Diagnostics
Table 43. Key Market Challenges & Risks of Infectious Disease Point of Care Diagnostics
Table 44. Key Industry Trends of Infectious Disease Point of Care Diagnostics
Table 45. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Abbott Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 52. Abbott Infectious Disease Point of Care Diagnostics Product Offered
Table 53. Abbott Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Abbott Main Business
Table 55. Abbott Latest Developments
Table 56. Siemens Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 57. Siemens Infectious Disease Point of Care Diagnostics Product Offered
Table 58. Siemens Main Business
Table 59. Siemens Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Siemens Latest Developments
Table 61. GE Healthcare Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 62. GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
Table 63. GE Healthcare Main Business
Table 64. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. GE Healthcare Latest Developments
Table 66. Accriva Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 67. Accriva Infectious Disease Point of Care Diagnostics Product Offered
Table 68. Accriva Main Business
Table 69. Accriva Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Accriva Latest Developments
Table 71. Terumo Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 72. Terumo Infectious Disease Point of Care Diagnostics Product Offered
Table 73. Terumo Main Business
Table 74. Terumo Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Terumo Latest Developments
Table 76. BioMerieux Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 77. BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
Table 78. BioMerieux Main Business
Table 79. BioMerieux Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. BioMerieux Latest Developments
Table 81. Diasorin Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 82. Diasorin Infectious Disease Point of Care Diagnostics Product Offered
Table 83. Diasorin Main Business
Table 84. Diasorin Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Diasorin Latest Developments
Table 86. Roche Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 87. Roche Infectious Disease Point of Care Diagnostics Product Offered
Table 88. Roche Main Business
Table 89. Roche Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Roche Latest Developments
Table 91. Danaher Corporation Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 92. Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
Table 93. Danaher Corporation Main Business
Table 94. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Danaher Corporation Latest Developments
Table 96. BD Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 97. BD Infectious Disease Point of Care Diagnostics Product Offered
Table 98. BD Main Business
Table 99. BD Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. BD Latest Developments
Table 101. Bio-Rad Laboratories Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 102. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
Table 103. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Bio-Rad Laboratories Main Business
Table 105. Bio-Rad Laboratories Latest Developments
Table 106. Cavidi Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 107. Cavidi Infectious Disease Point of Care Diagnostics Product Offered
Table 108. Cavidi Main Business
Table 109. Cavidi Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Cavidi Latest Developments
Table 111. Cepheid Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 112. Cepheid Infectious Disease Point of Care Diagnostics Product Offered
Table 113. Cepheid Main Business
Table 114. Cepheid Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cepheid Latest Developments
Table 116. Diaxonhit Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 117. Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
Table 118. Diaxonhit Main Business
Table 119. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Diaxonhit Latest Developments
Table 121. Eiken Chemical Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 122. Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
Table 123. Eiken Chemical Main Business
Table 124. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Eiken Chemical Latest Developments
Table 126. EMD Millipore Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 127. EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
Table 128. EMD Millipore Main Business
Table 129. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. EMD Millipore Latest Developments
Table 131. Epitope Diagnostic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 132. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
Table 133. Epitope Diagnostic Main Business
Table 134. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Epitope Diagnostic Latest Developments
Table 136. Euroimmun Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 137. Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
Table 138. Euroimmun Main Business
Table 139. Euroimmun Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Euroimmun Latest Developments
Table 141. Gold Standard Diagnostics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 142. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
Table 143. Gold Standard Diagnostics Main Business
Table 144. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Gold Standard Diagnostics Latest Developments
Table 146. Hologic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 147. Hologic Infectious Disease Point of Care Diagnostics Product Offered
Table 148. Hologic Main Business
Table 149. Hologic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Hologic Latest Developments
Table 151. Immunetics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 152. Immunetics Infectious Disease Point of Care Diagnostics Product Offered
Table 153. Immunetics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Immunetics Main Business
Table 155. Immunetics Latest Developments
Table 156. InBios International Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 157. InBios International Infectious Disease Point of Care Diagnostics Product Offered
Table 158. InBios International Main Business
Table 159. InBios International Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. InBios International Latest Developments
Table 1. Infectious Disease Point of Care Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Over-the-counter (OTC) Testing Kits
Table 3. Major Players of Prescription-based Testing Kits
Table 4. Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
Table 13. Infectious Disease Point of Care Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Infectious Disease Point of Care Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Infectious Disease Point of Care Diagnostics
Table 43. Key Market Challenges & Risks of Infectious Disease Point of Care Diagnostics
Table 44. Key Industry Trends of Infectious Disease Point of Care Diagnostics
Table 45. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Abbott Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 52. Abbott Infectious Disease Point of Care Diagnostics Product Offered
Table 53. Abbott Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Abbott Main Business
Table 55. Abbott Latest Developments
Table 56. Siemens Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 57. Siemens Infectious Disease Point of Care Diagnostics Product Offered
Table 58. Siemens Main Business
Table 59. Siemens Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Siemens Latest Developments
Table 61. GE Healthcare Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 62. GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
Table 63. GE Healthcare Main Business
Table 64. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. GE Healthcare Latest Developments
Table 66. Accriva Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 67. Accriva Infectious Disease Point of Care Diagnostics Product Offered
Table 68. Accriva Main Business
Table 69. Accriva Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Accriva Latest Developments
Table 71. Terumo Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 72. Terumo Infectious Disease Point of Care Diagnostics Product Offered
Table 73. Terumo Main Business
Table 74. Terumo Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Terumo Latest Developments
Table 76. BioMerieux Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 77. BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
Table 78. BioMerieux Main Business
Table 79. BioMerieux Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. BioMerieux Latest Developments
Table 81. Diasorin Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 82. Diasorin Infectious Disease Point of Care Diagnostics Product Offered
Table 83. Diasorin Main Business
Table 84. Diasorin Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Diasorin Latest Developments
Table 86. Roche Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 87. Roche Infectious Disease Point of Care Diagnostics Product Offered
Table 88. Roche Main Business
Table 89. Roche Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Roche Latest Developments
Table 91. Danaher Corporation Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 92. Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
Table 93. Danaher Corporation Main Business
Table 94. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Danaher Corporation Latest Developments
Table 96. BD Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 97. BD Infectious Disease Point of Care Diagnostics Product Offered
Table 98. BD Main Business
Table 99. BD Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. BD Latest Developments
Table 101. Bio-Rad Laboratories Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 102. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
Table 103. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Bio-Rad Laboratories Main Business
Table 105. Bio-Rad Laboratories Latest Developments
Table 106. Cavidi Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 107. Cavidi Infectious Disease Point of Care Diagnostics Product Offered
Table 108. Cavidi Main Business
Table 109. Cavidi Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Cavidi Latest Developments
Table 111. Cepheid Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 112. Cepheid Infectious Disease Point of Care Diagnostics Product Offered
Table 113. Cepheid Main Business
Table 114. Cepheid Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cepheid Latest Developments
Table 116. Diaxonhit Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 117. Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
Table 118. Diaxonhit Main Business
Table 119. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Diaxonhit Latest Developments
Table 121. Eiken Chemical Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 122. Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
Table 123. Eiken Chemical Main Business
Table 124. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Eiken Chemical Latest Developments
Table 126. EMD Millipore Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 127. EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
Table 128. EMD Millipore Main Business
Table 129. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. EMD Millipore Latest Developments
Table 131. Epitope Diagnostic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 132. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
Table 133. Epitope Diagnostic Main Business
Table 134. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Epitope Diagnostic Latest Developments
Table 136. Euroimmun Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 137. Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
Table 138. Euroimmun Main Business
Table 139. Euroimmun Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Euroimmun Latest Developments
Table 141. Gold Standard Diagnostics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 142. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
Table 143. Gold Standard Diagnostics Main Business
Table 144. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Gold Standard Diagnostics Latest Developments
Table 146. Hologic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 147. Hologic Infectious Disease Point of Care Diagnostics Product Offered
Table 148. Hologic Main Business
Table 149. Hologic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Hologic Latest Developments
Table 151. Immunetics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 152. Immunetics Infectious Disease Point of Care Diagnostics Product Offered
Table 153. Immunetics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Immunetics Main Business
Table 155. Immunetics Latest Developments
Table 156. InBios International Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 157. InBios International Infectious Disease Point of Care Diagnostics Product Offered
Table 158. InBios International Main Business
Table 159. InBios International Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. InBios International Latest Developments
LIST OF FIGURES
Figure 1. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2021
Figure 7. Infectious Disease Point of Care Diagnostics in Bacterial Infections
Figure 8. Global Infectious Disease Point of Care Diagnostics Market: Bacterial Infections (2017-2022) & ($ Millions)
Figure 9. Infectious Disease Point of Care Diagnostics in Fungal Infection
Figure 10. Global Infectious Disease Point of Care Diagnostics Market: Fungal Infection (2017-2022) & ($ Millions)
Figure 11. Infectious Disease Point of Care Diagnostics in Virus Infection
Figure 12. Global Infectious Disease Point of Care Diagnostics Market: Virus Infection (2017-2022) & ($ Millions)
Figure 13. Infectious Disease Point of Care Diagnostics in Cardiovascular Infection
Figure 14. Global Infectious Disease Point of Care Diagnostics Market: Cardiovascular Infection (2017-2022) & ($ Millions)
Figure 15. Infectious Disease Point of Care Diagnostics in Gastrointestinal Infection
Figure 16. Global Infectious Disease Point of Care Diagnostics Market: Gastrointestinal Infection (2017-2022) & ($ Millions)
Figure 17. Infectious Disease Point of Care Diagnostics in Sexually Transmitted Disease (STD) Infection
Figure 18. Global Infectious Disease Point of Care Diagnostics Market: Sexually Transmitted Disease (STD) Infection (2017-2022) & ($ Millions)
Figure 19. Infectious Disease Point of Care Diagnostics in Central Nervous System Infection
Figure 20. Global Infectious Disease Point of Care Diagnostics Market: Central Nervous System Infection (2017-2022) & ($ Millions)
Figure 21. Infectious Disease Point of Care Diagnostics in Other
Figure 22. Global Infectious Disease Point of Care Diagnostics Market: Other (2017-2022) & ($ Millions)
Figure 23. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 24. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player in 2021
Figure 25. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 26. Americas Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 27. APAC Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 28. Europe Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 29. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 30. Americas Infectious Disease Point of Care Diagnostics Value Market Share by Country in 2021
Figure 31. Americas Infectious Disease Point of Care Diagnostics Consumption Market Share by Type in 2021
Figure 32. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 33. United States Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Canada Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Mexico Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Brazil Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region in 2021
Figure 38. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 39. China Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Japan Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Korea Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. India Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Australia Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country in 2021
Figure 46. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2021
Figure 47. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 48. Germany Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. France Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. UK Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Italy Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Russia Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Region in 2021
Figure 54. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2021
Figure 55. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 56. Egypt Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 57. South Africa Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 58. Israel Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 59. Turkey Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 61. Americas Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. APAC Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. Europe Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. United States Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Canada Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. Mexico Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Brazil Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. China Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. Japan Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. Korea Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. India Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Australia Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Germany Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. France Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. UK Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 78. Italy Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 79. Russia Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 80. Spain Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 81. Egypt Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 82. South Africa Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 83. Israel Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 84. Turkey Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 85. GCC Countries Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 1. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2021
Figure 7. Infectious Disease Point of Care Diagnostics in Bacterial Infections
Figure 8. Global Infectious Disease Point of Care Diagnostics Market: Bacterial Infections (2017-2022) & ($ Millions)
Figure 9. Infectious Disease Point of Care Diagnostics in Fungal Infection
Figure 10. Global Infectious Disease Point of Care Diagnostics Market: Fungal Infection (2017-2022) & ($ Millions)
Figure 11. Infectious Disease Point of Care Diagnostics in Virus Infection
Figure 12. Global Infectious Disease Point of Care Diagnostics Market: Virus Infection (2017-2022) & ($ Millions)
Figure 13. Infectious Disease Point of Care Diagnostics in Cardiovascular Infection
Figure 14. Global Infectious Disease Point of Care Diagnostics Market: Cardiovascular Infection (2017-2022) & ($ Millions)
Figure 15. Infectious Disease Point of Care Diagnostics in Gastrointestinal Infection
Figure 16. Global Infectious Disease Point of Care Diagnostics Market: Gastrointestinal Infection (2017-2022) & ($ Millions)
Figure 17. Infectious Disease Point of Care Diagnostics in Sexually Transmitted Disease (STD) Infection
Figure 18. Global Infectious Disease Point of Care Diagnostics Market: Sexually Transmitted Disease (STD) Infection (2017-2022) & ($ Millions)
Figure 19. Infectious Disease Point of Care Diagnostics in Central Nervous System Infection
Figure 20. Global Infectious Disease Point of Care Diagnostics Market: Central Nervous System Infection (2017-2022) & ($ Millions)
Figure 21. Infectious Disease Point of Care Diagnostics in Other
Figure 22. Global Infectious Disease Point of Care Diagnostics Market: Other (2017-2022) & ($ Millions)
Figure 23. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 24. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player in 2021
Figure 25. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 26. Americas Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 27. APAC Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 28. Europe Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 29. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2017-2022 ($ Millions)
Figure 30. Americas Infectious Disease Point of Care Diagnostics Value Market Share by Country in 2021
Figure 31. Americas Infectious Disease Point of Care Diagnostics Consumption Market Share by Type in 2021
Figure 32. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 33. United States Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Canada Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Mexico Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Brazil Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region in 2021
Figure 38. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 39. China Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Japan Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Korea Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. India Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Australia Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country in 2021
Figure 46. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2021
Figure 47. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 48. Germany Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. France Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. UK Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Italy Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Russia Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Region in 2021
Figure 54. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2021
Figure 55. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2021
Figure 56. Egypt Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 57. South Africa Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 58. Israel Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 59. Turkey Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Infectious Disease Point of Care Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 61. Americas Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. APAC Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. Europe Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. United States Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Canada Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. Mexico Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Brazil Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. China Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. Japan Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. Korea Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. India Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Australia Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Germany Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. France Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. UK Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 78. Italy Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 79. Russia Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 80. Spain Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 81. Egypt Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 82. South Africa Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 83. Israel Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 84. Turkey Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
Figure 85. GCC Countries Infectious Disease Point of Care Diagnostics Market Size 2023-2028 ($ Millions)
